$AIRG
AIRGAIN INC

2023 Q4 Form 10-Q Financial Statement

#000095017023062233 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $10.07M $13.70M
YoY Change -49.37% -28.66%
Cost Of Revenue $7.140M $8.460M
YoY Change -49.03% -28.03%
Gross Profit $2.930M $5.236M
YoY Change -50.17% -29.65%
Gross Profit Margin 29.1% 38.23%
Selling, General & Admin $5.250M $4.848M
YoY Change -24.1% -16.5%
% of Gross Profit 179.18% 92.59%
Research & Development $3.168M $2.298M
YoY Change 41.43% -20.79%
% of Gross Profit 108.12% 43.89%
Depreciation & Amortization $903.0K $200.0K
YoY Change -2.9% 0.0%
% of Gross Profit 30.82% 3.82%
Operating Expenses $8.418M $7.146M
YoY Change -8.07% -17.93%
Operating Profit -$5.488M -$1.910M
YoY Change 67.47% 51.11%
Interest Expense $41.00K $30.00K
YoY Change 57.69% 15.38%
% of Operating Profit
Other Income/Expense, Net $7.000K $33.00K
YoY Change -143.75% -294.12%
Pretax Income -$5.440M -$1.877M
YoY Change 66.51% 50.52%
Income Tax $44.00K $4.000K
% Of Pretax Income
Net Earnings -$5.484M -$1.881M
YoY Change 70.31% 44.8%
Net Earnings / Revenue -54.46% -13.73%
Basic Earnings Per Share -$0.18
Diluted Earnings Per Share -$0.52 -$0.18
COMMON SHARES
Basic Shares Outstanding 10.44M 10.42M
Diluted Shares Outstanding 10.43M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.881M $9.990M
YoY Change -33.79% 8.71%
Cash & Equivalents $7.881M $9.989M
Short-Term Investments
Other Short-Term Assets $1.422M $2.040M
YoY Change -37.74% 1.75%
Inventory $2.403M $3.950M
Prepaid Expenses
Receivables $7.375M $6.272M
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.08M $22.25M
YoY Change -29.73% -25.81%
LONG-TERM ASSETS
Property, Plant & Equipment $2.507M $2.454M
YoY Change -49.68% -12.86%
Goodwill $10.85M $10.85M
YoY Change 0.0% 0.0%
Intangibles $8.234M $8.977M
YoY Change -26.5% -24.94%
Long-Term Investments
YoY Change
Other Assets $170.0K $170.0K
YoY Change -21.3% -30.04%
Total Long-Term Assets $23.15M $24.05M
YoY Change -15.04% -15.02%
TOTAL ASSETS
Total Short-Term Assets $19.08M $22.25M
Total Long-Term Assets $23.15M $24.05M
Total Assets $42.23M $46.30M
YoY Change -22.37% -20.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.472M $5.425M
YoY Change -0.54% -30.69%
Accrued Expenses $2.971M $3.750M
YoY Change -53.53% -34.88%
Deferred Revenue $17.00M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.991M $9.514M
YoY Change -22.55% -33.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $674.0K $880.0K
YoY Change -56.12% -50.62%
Total Long-Term Liabilities $674.0K $880.0K
YoY Change -56.12% -50.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.991M $9.514M
Total Long-Term Liabilities $674.0K $880.0K
Total Liabilities $10.82M $10.54M
YoY Change -25.79% -35.28%
SHAREHOLDERS EQUITY
Retained Earnings -$78.52M -$73.04M
YoY Change 18.8% 16.17%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.364M $5.364M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $31.41M $35.77M
YoY Change
Total Liabilities & Shareholders Equity $42.23M $46.30M
YoY Change -22.37% -20.57%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$5.484M -$1.881M
YoY Change 70.31% 44.8%
Depreciation, Depletion And Amortization $903.0K $200.0K
YoY Change -2.9% 0.0%
Cash From Operating Activities -$1.937M $640.0K
YoY Change -181.97% 521.36%
INVESTING ACTIVITIES
Capital Expenditures $174.0K $70.00K
YoY Change 34.88% -115.22%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$174.0K -$70.00K
YoY Change 38.1% -84.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.000K 70.00K
YoY Change -99.58% -29.29%
NET CHANGE
Cash From Operating Activities -1.937M 640.0K
Cash From Investing Activities -174.0K -70.00K
Cash From Financing Activities 2.000K 70.00K
Net Change In Cash -2.111M 640.0K
YoY Change -177.81% -348.06%
FREE CASH FLOW
Cash From Operating Activities -$1.937M $640.0K
Capital Expenditures $174.0K $70.00K
Free Cash Flow -$2.111M $570.0K
YoY Change -194.49% 1.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001272842
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37851
dei Entity Registrant Name
EntityRegistrantName
AIRGAIN, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4523882
dei Entity Address Address Line1
EntityAddressAddressLine1
3611 Valley Centre Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
760
dei Local Phone Number
LocalPhoneNumber
579-0200
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AIRG
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10443709
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9989000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11903000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6272000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8741000
CY2023Q3 us-gaap Inventory Net
InventoryNet
3950000
CY2022Q4 us-gaap Inventory Net
InventoryNet
4226000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2041000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2284000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
22252000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
27154000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2454000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2765000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1604000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2217000
CY2023Q3 us-gaap Goodwill
Goodwill
10845000
CY2022Q4 us-gaap Goodwill
Goodwill
10845000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8977000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11203000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
170000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
216000
CY2023Q3 us-gaap Assets
Assets
46302000
CY2022Q4 us-gaap Assets
Assets
54400000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5425000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6507000
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
642000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2874000
CY2023Q3 airg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
2538000
CY2022Q4 airg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
2615000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
909000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
904000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9514000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12900000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
145000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
139000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
878000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1536000
CY2023Q3 us-gaap Liabilities
Liabilities
10537000
CY2022Q4 us-gaap Liabilities
Liabilities
14575000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
34000
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
26000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
68000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10985000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10444000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10767000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10226000
CY2023Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
114166000
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
111282000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5364000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5364000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73037000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66093000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
35765000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
39825000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46302000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54400000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13696000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19198000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45970000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56006000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
8460000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
11755000
us-gaap Cost Of Revenue
CostOfRevenue
28137000
us-gaap Cost Of Revenue
CostOfRevenue
33902000
CY2023Q3 us-gaap Gross Profit
GrossProfit
5236000
CY2022Q3 us-gaap Gross Profit
GrossProfit
7443000
us-gaap Gross Profit
GrossProfit
17833000
us-gaap Gross Profit
GrossProfit
22104000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2298000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2901000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7337000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9117000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1704000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2808000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6875000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8552000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3144000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2998000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10533000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9738000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7146000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
8707000
us-gaap Operating Expenses
OperatingExpenses
24745000
us-gaap Operating Expenses
OperatingExpenses
27407000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1910000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1264000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6912000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5303000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
37000
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1000
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
9000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
16000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
39000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1877000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1247000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6860000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5305000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
134000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1881000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1299000
us-gaap Net Income Loss
NetIncomeLoss
-6944000
us-gaap Net Income Loss
NetIncomeLoss
-5439000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10430000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10210000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10370000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10179000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10430000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10210000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10370000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10179000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1881000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1299000
us-gaap Net Income Loss
NetIncomeLoss
-6944000
us-gaap Net Income Loss
NetIncomeLoss
-5439000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1881000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1299000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6944000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5439000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
37079000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
42248000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
39825000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44173000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
35765000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42012000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
35765000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42012000
us-gaap Profit Loss
ProfitLoss
-6944000
us-gaap Profit Loss
ProfitLoss
-5439000
us-gaap Depreciation
Depreciation
500000
us-gaap Depreciation
Depreciation
502000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2227000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2269000
us-gaap Share Based Compensation
ShareBasedCompensation
2472000
us-gaap Share Based Compensation
ShareBasedCompensation
3575000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
24000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2469000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1305000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-276000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
396000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-203000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
733000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-6000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-109000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1100000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2353000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1338000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-54000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-102000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1383000
airg Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-40000
airg Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-52000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1364000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2083000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
172000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
634000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
10000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-172000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-624000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7015000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
690000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
232000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
235000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-458000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6780000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1994000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5321000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12078000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14686000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10084000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9365000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
78000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
196000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
364000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
19000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9989000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9190000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
95000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
175000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10084000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9365000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1881000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1299000
us-gaap Net Income Loss
NetIncomeLoss
-6944000
us-gaap Net Income Loss
NetIncomeLoss
-5439000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10430000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10210000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10370000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10179000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10430000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10210000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10370000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10179000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2211000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2207000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2290000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2033000
CY2023Q3 us-gaap Cash
Cash
9719000
CY2022Q4 us-gaap Cash
Cash
8323000
CY2023Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
95000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
40000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
55000
CY2022Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
175000
CY2023Q3 airg Provision For Excess And Obsolete Inventories
ProvisionForExcessAndObsoleteInventories
1000000
CY2022Q4 airg Provision For Excess And Obsolete Inventories
ProvisionForExcessAndObsoleteInventories
900000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7343000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7170000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4889000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4405000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2454000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2765000
CY2023Q3 us-gaap Depreciation
Depreciation
200000
CY2022Q3 us-gaap Depreciation
Depreciation
200000
us-gaap Depreciation
Depreciation
500000
us-gaap Depreciation
Depreciation
500000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20095000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11118000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8977000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20095000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8892000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11203000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
742000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2968000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2958000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
557000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
356000
CY2023Q3 airg Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1396000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8977000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2300000
CY2023Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
879000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
815000
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
339000
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
339000
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
201000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
166000
CY2023Q3 airg Advanced Payments From Contract Manufacturers
AdvancedPaymentsFromContractManufacturers
124000
CY2022Q4 airg Advanced Payments From Contract Manufacturers
AdvancedPaymentsFromContractManufacturers
210000
CY2023Q3 airg Contract Liabilities Current
ContractLiabilitiesCurrent
0
CY2022Q4 airg Contract Liabilities Current
ContractLiabilitiesCurrent
32000
CY2023Q3 airg Goods Received Not Invoiced
GoodsReceivedNotInvoiced
821000
CY2022Q4 airg Goods Received Not Invoiced
GoodsReceivedNotInvoiced
529000
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
174000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
524000
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2538000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2615000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
5 years
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
21000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
300000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
200000
us-gaap Operating Lease Cost
OperatingLeaseCost
800000
us-gaap Operating Lease Cost
OperatingLeaseCost
800000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
266000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
902000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
687000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1855000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
70000
CY2023Q3 airg Unrealized Translation Gain
UnrealizedTranslationGain
2000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1787000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
909000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
878000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.012
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.025
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11900000
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4008000
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3825000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
523000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1120000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2472000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3575000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
200000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2065000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.78
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
758000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
297000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.56
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
40000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
304000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.65
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2046000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.65
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
281000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1461000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
11.36
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M12D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
281000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2046000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.65
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
281000
CY2022Q4 airg Severance And Exit Costs1
SeveranceAndExitCosts1
0
CY2023Q1 airg Accrued Expense Of Severanc Costs
AccruedExpenseOfSeverancCosts
205000
CY2023Q1 airg Payment Of Severance Costs
PaymentOfSeveranceCosts
-92000
CY2023Q1 airg Severance And Exit Costs1
SeveranceAndExitCosts1
113000
CY2023Q2 airg Accrued Expense Of Severanc Costs
AccruedExpenseOfSeverancCosts
365000
CY2023Q2 airg Payment Of Severance Costs
PaymentOfSeveranceCosts
-71000
CY2023Q2 airg Severance And Exit Costs1
SeveranceAndExitCosts1
407000
CY2023Q3 airg Accrued Expense Of Severanc Costs
AccruedExpenseOfSeverancCosts
-22000
CY2023Q3 airg Payment Of Severance Costs
PaymentOfSeveranceCosts
-385000
CY2023Q3 airg Severance And Exit Costs1
SeveranceAndExitCosts1
0
airg Accrual Warranty Expense
AccrualWarrantyExpense
100000
CY2022 airg Accrual Warranty Expense
AccrualWarrantyExpense
200000
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
2454000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2765000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13696000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19198000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45970000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56006000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13696000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19198000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45970000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56006000

Files In Submission

Name View Source Status
0000950170-23-062233-index-headers.html Edgar Link pending
0000950170-23-062233-index.html Edgar Link pending
0000950170-23-062233.txt Edgar Link pending
0000950170-23-062233-xbrl.zip Edgar Link pending
airg-20230930.htm Edgar Link pending
airg-20230930.xsd Edgar Link pending
airg-ex31_1.htm Edgar Link pending
airg-ex31_2.htm Edgar Link pending
airg-ex32_1.htm Edgar Link pending
airg-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
airg-20230930_pre.xml Edgar Link unprocessable
airg-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
airg-20230930_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
airg-20230930_cal.xml Edgar Link unprocessable
airg-20230930_def.xml Edgar Link unprocessable